Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nova Minerals Limited | QM3 | Nov 26, 2024 | 0.13 | +2.30 |
Nova Pacific Metals Corp. | YQ1 | Nov 26, 2024 | 0.12 | 0.00 |
Nova Pacific Metals Corp. | YQ10 | Nov 26, 2024 | 0.22 | -18.98 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | Nov 26, 2024 | 5.75 | -3.36 |
Novabay Pharmaceuticals | B9P | Nov 26, 2024 | 2.80 | 0.00 |
Novacyt | NYZ | Nov 26, 2024 | 0.55 | +2.22 |
Novagold Resources Inc. | NGR | Nov 26, 2024 | 3.36 | -1.53 |
Novanta Inc. - | 1GSN | Nov 26, 2024 | 165.00 | +1.85 |
Novartis AG | NOTA | Nov 26, 2024 | 96.80 | -1.83 |
Novavax, Inc. | NVV1 | Nov 26, 2024 | 8.38 | -5.96 |
Novem Group S.A. | NVM | Nov 26, 2024 | 5.74 | -0.69 |
NOVINA S.A. E ZY 1,16 | T36 | Nov 26, 2024 | 0.30 | +31.87 |
Novo Nordisk A/S | NOVA | Nov 26, 2024 | 101.00 | 0.00 |
Novo Resources Corp | 1NOR | Nov 26, 2024 | 0.05 | 0.00 |
NovoCure Limited - Ordinary Shares | 038 | Nov 26, 2024 | 16.93 | -0.99 |
NOVONIX ADR | GC30 | Nov 26, 2024 | 2.16 | 0.00 |
Novonix Limited | GC3 | Nov 26, 2024 | 0.56 | 0.00 |
NOVOTEK AB B SK-,25 | Z9D | Nov 26, 2024 | 5.76 | 0.00 |
Novozymes AS | NZM | Nov 26, 2024 | 56.00 | -0.89 |
Novozymes B | NZM2 | Nov 26, 2024 | 55.42 | -2.57 |
Novra Technologies Inc. | 7CV | Nov 26, 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | Nov 26, 2024 | 0.36 | -6.67 |
NOW Inc. | 11N | Nov 26, 2024 | 13.80 | -0.72 |
NP3 Fastigheter | N33 | Nov 26, 2024 | 21.25 | -1.39 |
NPC Inc | 59N | Nov 26, 2024 | 5.95 | +2.59 |
NRC Group | 8NR | Nov 26, 2024 | 0.30 | -2.63 |
NRG Energy Inc. | NRA | Nov 26, 2024 | 97.00 | +7.04 |
NRJ Group | NR8 | Nov 26, 2024 | 6.90 | 0.00 |
NRW Holdings Limited | 3NR | Nov 26, 2024 | 2.30 | 0.00 |
Ns United Kaiun Kaisha, Ltd. | 8WN | Nov 26, 2024 | 25.20 | -3.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.